Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,695 | -134,850 | -160,805 | -123,482 | -83,463 |
| Depreciation Amortization | -256 | -3,520 | -5,401 | -554 | 51 |
| Accounts payable and accrued liabilities | 421 | -4,024 | 458 | 4,506 | 3,290 |
| Other Working Capital | 336 | -12,430 | 8,297 | 9,850 | -4,027 |
| Other Operating Activity | 17,052 | 32,912 | 27,087 | 20,457 | 16,048 |
| Operating Cash Flow | $-84,142 | $-121,912 | $-130,364 | $-89,223 | $-68,101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -212 | -447 | -1,274 | -1,427 | -4,923 |
| Purchase Of Investment | -51,593 | -107,406 | -246,629 | -376,789 | N/A |
| Sale Of Investment | 134,391 | 194,109 | 292,560 | 142,800 | N/A |
| Investing Cash Flow | $82,586 | $86,256 | $44,657 | $-235,416 | $-4,923 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -435 | N/A | N/A | 10,000 | N/A |
| Debt Repayment | -929 | -827 | -388 | -388 | -281 |
| Common Stock Issued | 38 | 1,983 | 59,679 | 903 | 2,753 |
| Other Financing Activity | 1,688 | 29,661 | 0 | -655 | 0 |
| Financing Cash Flow | $362 | $30,817 | $59,291 | $9,860 | $2,472 |
| Beginning Cash Position | 17,633 | 22,472 | 48,888 | 363,667 | 434,219 |
| End Cash Position | 16,439 | 17,633 | 22,472 | 48,888 | 363,667 |
| Net Cash Flow | $-1,194 | $-4,839 | $-26,416 | $-314,779 | $-70,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,142 | -121,912 | -130,364 | -89,223 | -68,101 |
| Capital Expenditure | -212 | -447 | -1,274 | -1,427 | -4,923 |
| Free Cash Flow | -84,354 | -122,359 | -131,638 | -90,650 | -73,024 |